AVIR
AVIR
NASDAQ · Pharmaceuticals

Atea Pharmaceuticals Inc

$5.60
+0.17 (+3.13%)
As of Sep 22, 3:20 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 7 78%
Hold 2 22%
Sell 0 0%
Price Target
Analyst Price Target +722.3% upside
Low Target $31.54
Average Target $46.05
High Target $64.23
Current Price $5.60
Current
$5.60
Target
$46.05
$31.54 $46.05 avg $64.23
Scenario Analysis
Bear Case
$31.54
463.2%
Low target
Base Case
$46.05
+722.3%
Avg target
Bull Case
$64.23
+1,047.0%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$6.45
-13.2% from high
52-Week Low
$2.78
+101.4% from low
Target vs 52W High
$46.05
+614.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +188.0%